Duque P M, Alonso C, Sánchez-Prieto R, Lleonart M, Martínez C, de Buitrago G G, Cano A, Quintanilla M, Ramon y Cajal S
Department of Pathology, Clinica Puerta de Hierro, Madrid, Spain.
Cancer Gene Ther. 1999 Nov-Dec;6(6):554-63. doi: 10.1038/sj.cgt.7700077.
The adenovirus (Ad) E1A gene exerts an antitumor effect and can induce sensitivity to treatment with DNA-damaging agents. In contrast, the Ad 19-kDa E1B protein inhibits E1A-mediated apoptosis and the 55-kDa E1B inactivates the p53 protein. In this paper, we study the in vitro and in vivo effects of a 19-kDa and 55-kDa E1B-defective Ad in several malignant human tumor cell lines.
Nontumorigenic human fibroblasts (CCD-45SK and Hs67), peripheral blood lymphocytes, and several human tumor cell lines derived from cervix, colon, and breast carcinomas, epidermoid carcinoma, and osteosarcoma (HeLa, HT29, MCF7, Saos-2, and A431 cell lines) were studied. Wild-type (wt) Ad type 5 and H5 dL118 Ad, a mutant with the deleted E1B region, were employed. The cells were infected at 20 plaque-forming units, and cell viability was evaluated by the crystal violet method. In the in vivo experiments, 2 x 10(6) cells from the carcinoma cell lines HeLa, A431 and HT29 were injected into nude mice. The tumorigenicity of previously infected cells and after an intratumoral injection of Ad was analyzed. The mice received whole-body gamma-irradiation.
The H5 dL118 mutant produced a marked cytopathic effect in all of the malignant cells, surpassing that of the wt Ad; viability at 72 hours ranged from 11% to 20% for H5 dL118 Ad and from 70% to 93% for the wt Ad with respect to uninfected controls. In the in vivo experiments, a total inhibition of tumorigenicity was detected when cells were infected prior to injection and a partial and transitory decrease in tumorigenicity was detected when the mutant H5 dL118 was injected intratumorally. gamma-irradiation enhanced the in vivo antitumor effects.
These results indicate that infection with completely E1B-deficient Ads induced a marked cytopathic effect on malignant cells that was higher than that seen for wt Ads; in addition, infection with such Ads exerts a tumor suppressor effect in vivo.
腺病毒(Ad)E1A基因具有抗肿瘤作用,并可诱导对DNA损伤剂治疗的敏感性。相比之下,Ad 19-kDa E1B蛋白抑制E1A介导的细胞凋亡,而55-kDa E1B使p53蛋白失活。在本文中,我们研究了一种19-kDa和55-kDa E1B缺陷型Ad在几种恶性人类肿瘤细胞系中的体外和体内效应。
研究了非致瘤性人成纤维细胞(CCD-45SK和Hs67)、外周血淋巴细胞以及几种源自宫颈癌、结肠癌和乳腺癌、表皮样癌和骨肉瘤的人类肿瘤细胞系(HeLa、HT29、MCF7、Saos-2和A431细胞系)。使用野生型(wt)5型腺病毒和H5 dL118 Ad(一种E1B区域缺失的突变体)。细胞以20个空斑形成单位进行感染,并通过结晶紫法评估细胞活力。在体内实验中,将来自HeLa、A431和HT29癌细胞系的2×10⁶个细胞注射到裸鼠体内。分析先前感染的细胞以及瘤内注射Ad后的致瘤性。小鼠接受全身γ射线照射。
H5 dL118突变体在所有恶性细胞中产生了明显的细胞病变效应,超过了wt Ad;相对于未感染的对照,H5 dL118 Ad在72小时时的活力为11%至20%,wt Ad为70%至93%。在体内实验中,当细胞在注射前被感染时,检测到致瘤性完全抑制,当瘤内注射突变体H5 dL118时,检测到致瘤性部分且短暂降低。γ射线照射增强了体内抗肿瘤作用。
这些结果表明,完全缺乏E1B的腺病毒感染对恶性细胞诱导了明显高于wt腺病毒的细胞病变效应;此外,这种腺病毒感染在体内发挥肿瘤抑制作用。